RxSight Return on Equity (ROE) Growth & History (RXST)

RxSight's return on equity was −13.99% for fiscal 2025.

View full RxSight company overview

RxSight annual return on equity history

RxSight annual return on equity

Fiscal yearPeriod endedReturn on equityChange (percentage points)
20252025-12-31−13.99%−1.55 pp
20242024-12-31−12.43%+26.41 pp
20232023-12-31−38.85%+19.68 pp
20222022-12-31−58.52%

RxSight return on equity trends

Between the periods ended 2022-12-31 and 2025-12-31, RxSight's return on equity increased from −58.52% to −13.99%, a change of +44.54 percentage points. The latest reported quarter, Q2 2026, shows −4.56%.

About the metric

What return on equity (ROE) means

Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.

Calculation and source

How return on equity is calculated

TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review RxSight source filings ↗

Community posts

It’s quiet here.

No posts about RXST yet. Start the conversation.

Write the first post